Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M388Revenue (TTM) $M30.0Net Margin (%)-173.0Altman Z-Score11.0
Enterprise Value $M201EPS (TTM) $-0.7Operating Margin %-191.1Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.6Pre-tax Margin (%)-189.6Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %-1.6Quick Ratio18.9Cash flow > EarningsY
Price/Sales12.85-y EBITDA Growth Rate %-1.6Current Ratio18.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-23.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-26.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M70.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOFirst Eagle Investment 2016-03-31 Add$4.91 - $9.13
($6.04)
$ 5.51-9%Add 89.86%379,727
SGMOJoel Greenblatt 2015-09-30 Sold Out $5.64 - $10.86
($8.27)
$ 5.51-33%Sold Out0
SGMOFirst Eagle Investment 2015-09-30 Buy $5.64 - $10.86
($8.27)
$ 5.51-33%New holding200,000
SGMOFirst Eagle Investment 2015-06-30 Sold Out -0.02%$10.35 - $15.68
($12.96)
$ 5.51-57%Sold Out0
SGMOJoel Greenblatt 2015-06-30 Buy $10.35 - $15.68
($12.94)
$ 5.51-57%New holding30,334
SGMOJoel Greenblatt 2015-03-31 Sold Out -0.0021%$12.64 - $18.54
($15.47)
$ 5.51-64%Sold Out0
SGMOJoel Greenblatt 2014-12-31 Buy $9.85 - $16.53
($12.15)
$ 5.51-55%New holding17,441
SGMOFirst Eagle Investment 2014-06-30 Add0.01%$11.71 - $17.95
($14.37)
$ 5.51-62%Add 34.10%536,380
SGMOFirst Eagle Investment 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 5.51-71%Reduce -52.81%400,000
SGMOFirst Eagle Investment 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 5.51-45%Add 99.73%847,550
SGMOFirst Eagle Investment 2013-06-30 Add$7.31 - $10.65
($8.72)
$ 5.51-37%Add 41.45%424,350
SGMOFirst Eagle Investment 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 5.51-38%New holding300,000
SGMOFirst Eagle Investment 2010-03-31 Sold Out $4.76 - $6.63
($5.63)
$ 5.51-2%Sold Out0
SGMOFirst Eagle Investment 2009-12-31 Buy $5.04 - $8.09
($5.87)
$ 5.51-6%New holding470
SGMOFirst Eagle Investment 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.39)
$ 5.51-14%Sold Out0
SGMOFirst Eagle Investment 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 5.5131%New holding260,600
SGMOFirst Eagle Investment 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 5.5134%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2015-07-15Sell25,000$10.43-47.17view
Wolff Henry WardExec VP & CFO 2015-07-13Sell12,000$10-44.9view
LANPHIER EDWARD O IIPresident & CEO 2015-06-15Sell25,000$11.08-50.27view
Wolff Henry WardExec VP & CFO 2015-06-10Sell12,000$12.21-54.87view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-06-05Sell15,000$12.29-55.17view
RINGO WILLIAM RDirector 2015-06-03Sell2,200$12.44-55.71view
Gregory Philip DSVP of Research & CSO 2015-06-01Sell15,000$12.39-55.53view
LANPHIER EDWARD O IIPresident & CEO 2015-05-15Sell25,000$11.51-52.13view
Wolff Henry WardExec VP & CFO 2015-05-11Sell12,000$13.25-58.42view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-05-05Sell15,000$12.29-55.17view

Quarterly/Annual Reports about SGMO:

News about SGMO:

Articles On GuruFocus.com
Biogen or Bluebird: Which Will Lead in SCD? Apr 30 2015 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 

More From Other Websites
Sangamo BioSciences Gets FDA Approval For IND For ZFN-Mediated Genome Editing Treatment Of MPS II Jun 20 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated... Jun 20 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated... Jun 20 2016
SANGAMO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Jun 15 2016
Premarket Research Report Covering the Biotech Industry Jun 15 2016
Sangamo BioSciences, Inc. breached its 50 day moving average in a Bearish Manner : SGMO-US : June... Jun 13 2016
Sangamo BioSciences Announces Presentation at the Jefferies 2016 Healthcare Conference Jun 01 2016
Sangamo BioSciences Announces Presentation at the Jefferies 2016 Healthcare Conference Jun 01 2016
Sangamo BioSciences Announces Retirement Of Edward Lanphier As President And CEO; Sandy Macrae Named... Jun 01 2016
SANGAMO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 01 2016
Sangamo BioSciences Announces Retirement Of Edward Lanphier As President And CEO; Sandy Macrae Named... Jun 01 2016
Sangamo BioSciences, Inc. breached its 50 day moving average in a Bullish Manner : SGMO-US : May 23,... May 23 2016
SANGAMO BIOSCIENCES INC Financials May 13 2016
Sangamo BioSciences Announces Participation At Upcoming Investor Conferences May 10 2016
Sangamo BioSciences Announces Participation At Upcoming Investor Conferences May 10 2016
Sangamo BioSciences Presents Recent Developments From Research And ZFP Therapeutic® Programs In... May 09 2016
Sangamo BioSciences Presents Recent Developments From Research And ZFP Therapeutic® Programs In... May 09 2016
7 Stocks Under $10 to Trade for Big Profits May 06 2016
ETF’s with exposure to Sangamo BioSciences, Inc. : May 5, 2016 May 05 2016
SANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report May 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)